Finasteride

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4090 publications

Editorial Comment on "Endoscopic Outlet Surgery vs Medical Therapy for Benign Prostatic Hyperplasia: Impact on Incident Mood Disorders" and "Safety and Efficacy of Prostatic Urethral Lift for Lower Urinary Tract Symptoms in Men with a History of Prostate Radiation.

Editorial Comment on "Endoscopic Outlet Surgery vs Medical Therapy for Benign Prostatic Hyperplasia: Impact on Incident Mood Disorders" and "Safety and Efficacy of Prostatic Urethral Lift for Lower Urinary Tract Symptoms in Men with a History of Prostate Radiation.

Journal: Urology

Published: August 16, 2026

SAFETY OF TAMSULOSIN ALONE OR IN COMBINATION WITH 5Α-REDUCTASE INHIBITORS ON LIPID PROFILE, RENAL FUNCTION, AND LIVER PARAMETERS.

SAFETY OF TAMSULOSIN ALONE OR IN COMBINATION WITH 5Α-REDUCTASE INHIBITORS ON LIPID PROFILE, RENAL FUNCTION, AND LIVER PARAMETERS.

Journal: Georgian medical news

Published: August 15, 2026

Corrigendum: The Role of Reactive Oxygen Species, Inflammation, and Endoplasmic Reticulum Stress Response in the Finasteride Protective Effect against Benign Prostate Hyperplasia.

Corrigendum: The Role of Reactive Oxygen Species, Inflammation, and Endoplasmic Reticulum Stress Response in the Finasteride Protective Effect against Benign Prostate Hyperplasia.

Journal: The world journal of men's health

Published: August 06, 2026

Concurrent Jackstone Calculus and Prostate Cancer: Should They Be Treated Concurrently or Sequentially?

Concurrent Jackstone Calculus and Prostate Cancer: Should They Be Treated Concurrently or Sequentially?

Journal: American journal of men's health

Published: July 30, 2026

Response to: "finasteride prescribed for hair loss consistently leads to depression".

Response to: "finasteride prescribed for hair loss consistently leads to depression".

Journal: Postgraduate medicine

Published: July 27, 2026

Finasteride prescribed for hair loss consistently leads to depression. Comment on 'Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement'.

Finasteride prescribed for hair loss consistently leads to depression. Comment on 'Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement'.

Journal: Postgraduate medicine

Published: July 24, 2026

Efficacy and safety of oral finasteride versus dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran.

Efficacy and safety of oral finasteride versus dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran.

Journal: The Journal of dermatological treatment

Published: July 17, 2026

Analytical quality-by-design-guided green RP-HPLC method to quantify cyclosporin A and luteolin simultaneously in a combination of two drug solutions and two drug-loaded next-generation emulsions or nanocapsules.

Analytical quality-by-design-guided green RP-HPLC method to quantify cyclosporin A and luteolin simultaneously in a combination of two drug solutions and two drug-loaded next-generation emulsions or nanocapsules.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: July 08, 2026

Unexpected Hair Regrowth Following Oral Bicalutamide Exposure in a Male Patient With Androgenetic Alopecia and a Suboptimal Response to Conventional Therapies: A Case Report.

Unexpected Hair Regrowth Following Oral Bicalutamide Exposure in a Male Patient With Androgenetic Alopecia and a Suboptimal Response to Conventional Therapies: A Case Report.

Journal: Cureus

Published: July 06, 2026

Botulinum toxin A for the Treatment of Androgenetic Alopecia: A Review.

Botulinum toxin A for the Treatment of Androgenetic Alopecia: A Review.

Journal: Cureus

Published: June 25, 2026

No Evidence of Post-Finasteride Syndrome in 267,983 Person-Years Follow-up in the Prostate Cancer Prevention Trial.

No Evidence of Post-Finasteride Syndrome in 267,983 Person-Years Follow-up in the Prostate Cancer Prevention Trial.

Journal: Urology

Published: June 23, 2026

A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia - Sex Hormone And Urinary Control Effects.

A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia - Sex Hormone And Urinary Control Effects.

Journal: Journal of visualized experiments : JoVE

Published: June 22, 2026

Showing 1-12 of 4,090

Last Updated: 09/26/2026